95363 ⎘
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups - in which the condensed system contains two hetero rings Bridged systems
MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS
#2HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF
#3HIV INHIBITOR COMPOUNDS
#43A,4,5,6-TETRAHYDRO-1 H-PYRAZOLO[3,4-C]PYRIDIN-7(7AH)-ONE DERIVATIVES AS FACTOR XIIA INHIBITORS
#5COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, SYNTHESIS METHOD THEREFOR AND USE THEREOF
#6NOVEL DERIVATIVES HAVING 2,3-DIHYDRO-1H-INDENE OR 2,3-DIHYDROBENZOFURAN MOIETY OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
#7METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION
#8BCL-XL/BCL-2 DEGRADERS AND USES THEREOF
#9ISOQUINOLONES AS PI3K INHIBITORS
#10ANTI-VIRAL COMPOUNDS
#11SULFONYL CARBOXAMIDE COMPOUND, THEIR DERIVATIVES, AND USES THEREOF
#12SERIES OF NITROGEN-CONTAINING BRIDGED HETEROCYCLIC COMPOUNDS AND PREPARATION METHOD THEREFOR
#13ALKYNYL QUINAZOLINE COMPOUNDS
#14PIPERIDYLUREA COMPOUNDS AND METHODS OF USE THEREOF
#15INHIBITOR CONTAINING BICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF
#16HETEROCYCLIC RING-SUBSTITUTED AROMATIC COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF
#17GLP-1R AGONISTS AND USES THEREOF
#185-METHOXY-N,N-DIMETHYLTRYPTAMINE ANALOGS, THEIR SYNTHESIS, AND METHODS FOR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC, AND SUBSTANCE USE DISORDERS
#19ISOQUINOLIN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF
#20PAN-KRAS INHIBITORS
#21CRYSTALLINE FORMS OF CFTR MODULATORS
#22UREA DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF
#23AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF
#24METHODS AND COMPOSITIONS OF INHIBITING DCN1-UBC12 INTERACTION
#25SELECTIVE SIGMA-2 RECEPTOR LIGANDS AS MODULATORS OF TMEM97
#26DURLOBACTAM CRYSTALLINE FORMS
#27ARNT Degrading Compounds and Uses Thereof
#28COMPOUNDS, COMPOSITIONS, AND METHODS
#29Heterocyclic Compounds as Immunomodulators of PD-L1 Interactions
#30Benzodiazepine Derivatives as RSV Inhibitors
#31SUBSTITUTED THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS
#324-(3H-PYRAZOLO[4,3-F]QUINOLIN-7-YL)-N-(2-(DIMETHYLAMINO)ETHYL)BENZAMIDE- OR HYDROXAMIC ACID COMPOUNDS, COMPOSITIONS, AND METHODS OF USE
#33THYROID HORMONE RECEPTOR AGONISTS AND USE THEREOF
#34AMINOHETEROARYL KINASE INHIBITORS
#35ALPHA 4 BETA 7 INTEGRIN MODULATORS AND USES THEREOF
#36HETEROCYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF CANCER
#37EGFR INHIBITORS
#38TROPOMYOSIN-RELATED KINASE (TRK) INHIBITORS
#39PTPN2/PTP1B Degrader and Therapeutic Method Thereof
#40Benzisoxazole Derivatives and Uses thereof
#41COMPOUNDS AND METHODS OF THEIR USE
#42COMPOSITIONS AND METHODS FOR INHIBITION OF RAS
#43SOS1 INHIBITORS
#44NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
#45KRAS INHIBITORS
#46NON-HYDROXAMATE HDAC6 INHIBITORS AND RELATED METHODS OF USE
#47HISTONE DEACETYLASE 6 INHIBITOR COMPOUNDS AND USES THEREOF
#48COMPOUNDS, PREPARATION METHODS AND USES THEREOF
#49UREA-GLYOXAL CROSSLINKING COMPOUNDS FOR PHENOLIC BINDER COMPOSITIONS
#50PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND USES THEREOF
#511,4-Substituted Piperidine Derivatives
#52HETEROCYCLIC COMPOUND
#53CRBN E3 LIGASE LIGAND COMPOUND, PROTEIN DEGRADER DEVELOPED BASED THEREON AND THEIR APPLICATIONS
#54IMIDAZOLYL PYRIMIDINYLAMINE COMPOUNDS AS CDK2 INHIBITORS
#55COMPOUNDS FOR THE TREATMENT OF BRAF-ASSOCIATED DISEASES AND DISORDERS
#56BICYCLIC TETRAHYDROAZEPINE DERIVATIVES
#57MONO- OR DI-SUBSTITUTED INDOLE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS
#58COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
#59PYRIDINYLACETAMIDE DERIVATIVES AS SODIUM CHANNEL ACTIVATORS
#60COMPOUND AS KIF18A INHIBITOR
#61BICYCLIC HETEROCYCLES AND THEIR LIGANDS FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS
#62SUBSTITUTED TETRAHYDROFURAN ANALOGS AS MODULATORS OF SODIUM CHANNELS
#63NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATION THEREOF
#64PI3K INHIBITORS
#65SUBSTITUTED 3-AMINO INDAZOLE DERIVATIVES AS KINASE INHIBITORS
#66COMPOUND HAVING ANTI-TUMOR ACTIVITY AND USE THEREOF
#67IBOGAINE AND NORIBOGAINE ANALOGS AND USES THEREOF
#68HDAC6 INHIBITORS AND USES THEREOF
#69HETEROCYCLIC INHIBITORS OF GLUT9 FOR TREATMENT OF DISEASE
#70COMPOUNDS, COMPOSITIONS, AND METHODS
#71HETEROCYCLIC COMPOUNDS AND USES THEREOF
#72COMPOUNDS AND METHODS OF USE
#73HETEROCYCLIC INHIBITORS OF IGF-1R FOR TREATMENT OF DISEASE
#74MATERIALS FOR ELECTRONIC DEVICES
#75BCL-XL/BCL-2 DUAL DEGRADERS FOR TREATMENT OF CANCERS
#76MATERIAL FOR METAL PATTERNING, HETEROCYCLIC COMPOUND, THIN FILM FOR METAL PATTERNING, ORGANIC ELECTROLUMINESCENT DEVICE, ELECTRONIC DEVICE, AND METHOD FOR FORMING METAL PATTERN
#77SIGMA-2 RECEPTOR LIGAND DRUG CONJUGATES AS ANTITUMOR COMPOUNDS, METHODS OF SYNTHESIS AND USES THEREOF
#78PYRIDINE DERIVATIVE AND USE THEREOF
#79PTPN2/PTP1B degrader and therapeutic method thereof
#80PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS
#81FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF
#82COMPOSITIONS AND METHODS COMPRISING SUBSTITUTED N-(2-CHLORO-6-METHYLPHENYL)-2-((6-(6-MEMBERED HETEROCYCLOALKYL)-2-METHYLPYRIMIDIN-4-YL)AMINO)THIAZOLE-5-CARBOXAMIDE ANALOGUES
#83HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS
#84NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
#85BENZAMIDES OF PYRAZOLYLAMINO- PYRIMIDINYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF
#86QUINOLINE cGAS ANTAGONIST COMPOUNDS
#872-PYRAZOLE ANILINES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD
#88CYCLOALKYL PYRIMIDINES AS FERROPORTIN INHIBITORS
#89HETEROCYCLIC RIP1 INHIBITORY COMPOUNDS
#90RIPK3 INHIBITORS AND METHODS OF USE
#91HUPERZINE B CRYSTAL AND PREPARATION AND APPLICATION THEREOF
#922-AMINO-N-HETEROARYL-NICOTINAMIDES AS NAV1.8 INHIBITORS
#93HETEROCYCLIC SULFONAMIDE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
#94RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF
#95NOVEL BISPIDINE-BASED METAL CHELATING LIGANDS DISPLAYING GOOD RELAXIVITY
#96CRYSTALLINE FORMS OF DIAZABICYCLOOCTANE DERIVATIVE AND PRODUCTION PROCESS THEREOF
#97Heterocyclic Compounds and Methods of Use
#98TLR MODULATOR AND USE THEREOF
#99KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
#100BIFUNCTIONAL SELECTIVE DEGRADERS OF SMARCA2 AND THERAPEUTIC USES THEREOF
#101Crystalline forms of CFTR modulators
#102HIV INHIBITOR COMPOUNDS
#1031,4-DIHETEROCYCLIC SUBSTITUTED AROMATIC RING OR AROMATIC HETEROCYCLIC COMPOUND AND USE THEREOF
#104LPAR1 ANTAGONISTS AND USES THEREOF
#105KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE
#106GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
#107SUBSTITUTED QUINOLINES AS IMPROVED NF-KB-INDUCING KINASE (NIK) INHIBITORS
#108COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES
#109CHROMANE AMIDINE MONOBACTAM ANTIBIOTICS
#1106-SUBSTITUTED INDOLE COMPOUNDS
#111SULFAMIDE RIBONUCLEOTIDE REDUCTASE (RNR) INHIBITORS AND USES THEREOF
#112BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6
#113BETA-LACTAMASE INHIBITORS AND USES THEREOF
#114COMPOUNDS TARGETING MUTANT OF P53
#115COMPOUNDS AND METHODS FOR MODULATING SPLICING
#116C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
#117HETERO-ATOM CONTAINING COMPOUNDS AND USES THEREOF
#118RING-MODIFIED PROLINE SHORT PEPTIDE COMPOUND AND USE THEREOF
#119DIAZABICYCLOOCTANONES AS INHIBITORS OF SERINE BETA-LACTAMASES
#120Substituted Quinoxalines
#121DIOXAZINES AND THEIR USE IN TREATMENT OF GBA-RELATED DISEASES
#122THERAPEUTIC COMPOUNDS
#123COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE
#124TLR7/8 ANTAGONISTS AND USES THEREOF
#125THERAPEUTIC COMPOUNDS
#126INHIBITORS OF TRANSGLUTAMINASES
#127CHELATE COMPOUNDS
#128COMPOUNDS AND METHODS FOR MODULATING SPLICING
#129BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS
#130SULPHONYL UREA DERIVATIVES AS NLRP3 INFLAMMASOME MODULATORS
#131RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
#132PROCESS FOR THE PREPARATION OF OPTICALLY PURE ENANTIOMERS OF CYCLIC IMINIUM SALTS AND THEIR USE AS CATALYSTS
#133GADOLINIUM BEARING PCTA-BASED CONTRAST AGENTS
#134INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7)
#135Benzodiazepine derivatives as RSV inhibitors
#136BRUTON'S TYROSINE KINASE AND MUTANT DEGRADER, COMPOSITION AND APPLICATION THEREOF
#137ANALOGS FOR THE TREATMENT OF DISEASE
#138PARP7 INHIBITOR AND USE THEREOF
#139HETEROCYCLOALKYL-SUBSTITUTED POLYHETEROAZOLE DERIVATIVES AS MEDICAMENTS FOR TREATING AND/OR PREVENTING RS VIRUS INFECTIONS
#140BTK INHIBITORS
#141INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN
#142GRAM-NEGATIVE BACTERIA EFFLUX PUMP INHIBITORS
#143KRAS G12D INHIBITORS
#144COMPOSITIONS AND METHODS FOR INHIBITION OF RAS
#145Phenothiazinyl Compounds and Uses
#146TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN
#147nSMASE2 INHIBITOR PRODRUGS WITH ENHANCED ORAL AND BRAIN EXPOSURES
#148SUBSTITUTED BENZODIAZOLES AND USE THEREOF IN THERAPY
#149BISPIDINE DERIVATIVES AND THE USE THEREOF
#150MOLECULAR PROBES FOR IN VIVO DETECTION OF ALDEHYDES
#151PHENOL RIBONUCLEOTIDE REDUCTASE (RNR) INHIBITORS AND USES THEREOF
#152COMPOSITIONS AND USES THEREOF
#153NOVEL BISPIDONE LIGANDS AND TRANSITION METAL COMPLEXES THEREOF
#154Cathinone Derivatives, Pharmaceutical Formulations, and Methods
#155EBNA1 Inhibitors and Methods Using Same
#156SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT
#157RIPK1 INHIBITORS AND METHODS OF USE
#158QUINUCLIDINONE ANALOGUES AS ANTICANCER AGENTS
#159BICYCLIC SUBSTITUTED AROMATIC CARBOXYLIC ACID COMPOUNDS
#160Five- and six-membered compound, and preparation method therefor and pharmaceutical composition and use thereof
#161Thyroid hormone receptor agonists and use thereof
#162SUBSTITUTED QUINOLINONE-8-CARBONITRILE DERIVATIVES HAVING ANDROGEN DEGRADATION ACTIVITY AND USES THEREOF
#163Tropomyosin-related kinase (trk) inhibitors
#164UREA-GLYOXAL CROSSLINKING COMPOUNDS FOR PHENOLIC BINDER COMPOSITIONS
#165METHODS AND COMPOSITIONS FOR SUBSTITUTED ARYLCYCLOHEPTANE ANALOGS
#166Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
#167HETEROCYCLIC COMPOUNDS CAPABLE OF ACTIVATING STING
#168HETEROCYCLIC COMPOUNDS CAPABLE OF ACTIVATING STING
#169MODULATORS OF THE INTEGRATED STRESS PATHWAY
#170Modulators of complex I
#171BRIDGED COMPOUNDS AS KRAS G12D INHIBITOR AND DEGRADER AND THE USE THEREOF
#172Cycloalkyl pyrimidines as ferroportin inhibitors
#173FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30) INHIBITORS
#174Azabicyclo and diazepine derivatives
#175IONIC COMPOUND, ABSORBENT AND ABSORPTION DEVICE
#176MUTANT PI3K-ALPHA INHIBITORS AND THEIR USE AS PHARMACEUTICALS
#177Morphinan compounds
#178INDOLO[3.2.1-JK]CARBAZOLE-6-CARBONITRILE DERIVATIVES AS BLUE FLUORESCENT EMITTERS FOR USE IN OLEDS
#179BRIDGED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE COMPOUNDS, PREPARATION METHOD AND MEDICAL USE THEREOF
#180EP300/CBP MODULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF
#181CARBONYL HETEROCYCLIC COMPOUND AND APPLICATION THEREOF
#182DIHYDROISOQUINOLINONE DERIVATIVE AND APPLICATION THEREOF
#183MORPHINAN COMPOUNDS
#184Quinoline cGAS antagonist compounds
#185Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof
#186CYCLIC AMINE DERIVATIVES HAVING SEROTONIN RECEPTOR BINDING ACTIVITY
#187MODIFIED ISOINDOLINONES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
#188ENZYME INHIBITORS
#189Small molecule inhibitors targeting sporulation
#190SULFONAMIDES WITH EGFR INHIBITION ACTIVITIES AND THEIR USE THEREOF
#191KRAS G12D INHIBITORS
#192Benzamides of pyrazolylamino-pyrimidinyl derivatives, and compositions and methods thereof
#193PROCESS FOR THE PREPARATION OF (9S)-N-[3-(6-METHYLPYRIMIDIN-4-YL)-3-AZABICYCLO[3.2.1]OCTAN-8-YL]-9-(2,3,4-TRIFLUOROPHENYL)-6,7,8,9-TETRAHYDRO-5H-[1,2,4]TRIAZOLO[1,5-A]AZEPIN-2-AMINE AND ITS SOLID FORM
#194LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING LIGHT-EMITTING DEVICE
#195Benzamides of pyrazolylamino-pyrimidinyl derivatives, and compositions and methods thereof
#196N-LINKED ISOQUINOLINE AMIDES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
#197ARYL DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS
#1981,4-substituted piperidine derivatives
#199LACTIVICIN COMPOUNDS, THEIR PREPARATION AND USE AS ANTIBACTERIAL AGENTS
#200MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#201BETA-LACTAMASE INHIBITORS AND THEIR PREPARATION
#202PYRIDAZINE DERIVATIVES FOR MODULATING NUCLEIC ACID SPLICING
#203FXR SMALL-MOLECULE AGONIST, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#204Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders
#205COMPOUND CAPABLE OF INHIBITING AND DEGRADING ANDROGEN RECEPTORS, AND PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICAL USES THEREOF
#206CASEIN KINASE 1 DELTA MODULATORS
#207METHOD FOR PREPARING A CHELATING LIGAND DERIVED FROM PCTA
#208CXCR6 SULFONAMIDE COMPOUNDS
#209COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE
#210Processes for preparing a diazabicyclooctane compound
#211RIP1 Inhibitory Compounds and Methods for Making and Using the Same
#212Ring-modified proline short peptide compound and use thereof
#213METHOD FOR PREPARING MORPHINAN DERIVATIVE HAVING DIARYL ETHER SKELETON USING NOVEL COPPER CATALYST
#214METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION
#2152-OXO-IMIDAZOLIDINE-4-CARBOXAMIDES AS NAV1.8 INHIBITORS
#216QUINOLINE COMPOUNDS
#217METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C
#2182-AMINOQUINAZOLINES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
#219NOVEL IMIDAZOLE-PYRAZOLE DERIVATIVES
#220NLRP3 MODULATORS
#221ANTAGONIST COMPOUNDS
#222Isoquinolin-3-yl carboxamides and preparation and use thereof
#223Morphinan derivatives and use thereof
#2242-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD
#225Compounds useful as inhibitors of ATR kinase
#226Pan-tropic entry inhibitors
#227GLP-1R MODULATING COMPOUNDS
#228ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF
#229Substituted Alkynylene Compounds As Anticancer Agents
#230PYRIDINYLACETAMIDE DERIVATIVES AS SODIUM CHANNEL ACTIVATORS
#231BETA-LACTAMASE INHIBITORS AND USES THEREOF
#232Methods for Treating Huntington’s Disease
#233METHODS AND COMPOSITIONS FOR TARGETING PD-L1
#234MACROCYCLIC AND CAGE-LIKE MOLECULE BASED ON BIPHEN[n]ARENE AND DERIVATIVE, SYNTHESIS METHOD AND USE THEREOF
#235COMPOUNDS AND METHODS FOR MODULATING SPLICING
#236SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION
#237CHEMICAL COMPOUNDS
#238MORPHINAN DERIVATIVE
#239COMPOUNDS AND METHODS FOR MODULATING SPLICING
#240PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS
#241FACTOR XI ACTIVATION INHIBITORS
#242Sulphonyl urea derivatives as NLRP3 inflammasome modulators
#243TARGETED NITROXIDE AGENTS
#244HETEROCYCLIC RIP1 INHIBITORY COMPOUNDS
#245PYRIDAZINE DERIVATIVES FOR MODULATING NUCLEIC ACID SPLICING
#246Substituted aminothiazoles as DGKzeta inhibitors for immune activation
#247Hormone receptor modulators for treating metabolic conditions and disorders
#248SOS1 inhibitors
#249NAMPT MODULATORS
#250ALPHA-METHYL-SUBSTITUTED DIAZABICYCLO[4.3.1] DECANE DERIVATIVES FOR TREATMENT OF PSYCHIATRIC DISORDERS
#251Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors
#252GPR84 ANTAGONISTS AND USES THEREOF
#253RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
#254Therapeutic compounds
#255COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS
#256Receptor inhibitor, pharmaceutical composition comprising same, and use thereof
#257sGC STIMULATORS
#258TRNA SYNTHETASE INHIBITORS
#259Crystalline forms of 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one hemihydrate
#260MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS
#261COMPOUND USED AS KINASE INHIBITOR AND USE THEREOF
#262Benzodiazepine derivatives as RSV inhibitors
#263AZEPANE DERIVATIVE
#264PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#265Quinoline cGAS antagonist compounds
#266Tropomyosin-related kinase (Trk) inhibitors
#267INHIBITORS OF ANOCTAMIN 6 PROTEIN AND USES THEREOF
#268ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD AND USE THEREOF
#269Substituted indoles and methods of use thereof
#270Antimicrobial Compounds and Methods
#271METHODS AND COMPOSITIONS FOR MODULATING SPLICING
#272HETEROCYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF CANCER
#273COMPOUNDS
#274PPARg MODULATORS AND METHODS OF USE
#275INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7)
#276Methods and compositions for modulating splicing
#277HETEROCYCLIC RIP1 KINASE INHIBITORS
#278Phenoxy-pyridyl-pyrimidine compounds and methods of use
#279EGFR inhibitors
#280COMPOUNDS AND METHODS OF USE
#2811,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES
#282New compounds for treatment of diseases related to DUX4 expression
#283SMALL MOLECULE RPN13 INHIBITORS WITH ANTITUMOR PROPERTIES
#284MATRIPTASE 2 INHIBITORS AND USES THEREOF
#2852,3-DISUBSTITUTED 1-ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS
#286Sulfonamide carboxamide compounds
#287METHODS AND COMPOSITIONS FOR MODULATING SPLICING
#288HIV inhibitor compounds
#289EGFR inhibitors
#290Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors
#291BICYCLIC COMPOUND AND USE THEREOF
#292METHODS AND COMPOSITIONS FOR MODULATING SPLICING
#293Benzolactam compounds as protein kinase inhibitors
#2941-AMINOSULFONYL-2-CARBOXYPYRROLE DERIVATIVES AS METALLO-BETA-LACTAMASE INHIBITORS
#295HETEROCYCLIC TRPML1 AGONISTS
#296Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides
#297METHODS AND COMPOSITIONS FOR MODULATING SPLICING
#298Small molecule inhibitors targeting sporulation
#299NOVEL COMPOUNDS HAVING INHIBITORY ACTIVITY AGAINST GLUCOSYLCERAMIDE SYNTHASE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PROCESSES FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
#300NOVEL DERIVATIVES HAVING 2,3-DIHYDRO-1H-INDENE OR 2,3-DIHYDROBENZOFURAN MOIETY OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME